243 results on '"Fragai M"'
Search Results
2. Combining Solid-State NMR with Structural and Biophysical Techniques to Design Challenging Protein-Drug Conjugates
3. Solving the crystal structure of human calcium-free S100Z: the siege and conquer of one of the last S100 family strongholds
4. Identification and characterization of an RRM-containing, ELAV-like, RNA binding protein in Acinetobacter Baumannii
5. Mixing Aβ(1-40) and Aβ(1-42) peptides generates unique amyloid fibrils
6. Fucose-binding lectin from Burkholderia ambifaria (BamBL) in complex with a fucosyl derivative
7. Stromal interaction molecule 1 coiled-coil 1 fragment
8. Mixing Abeta(1-40) and Abeta(1-42) peptides generates unique amyloid fibrils
9. Human MMP12 (catalytic domain) in complex with AP316
10. Sad phasing on nickel-substituted human carbonic anhydrase II
11. Crystal structure of E. coli L-asparaginase II
12. When molecular replacement has no trivial solution: The importance of model editing in human S100Z X-ray structure solution
13. Interdomain Flexibility in Full-length Matrix Metalloproteinase-1 (MMP-1)*S⃞
14. Crystal structure of calcium-free human S100Z
15. A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome
16. Examination of Matrix Metalloproteinase-1 in Solution: A PREFERENCE FOR THE PRE-COLLAGENOLYSIS STATE
17. The structure of the NK1 fragment of HGF/SF complexed with (H)EPPS
18. The structure of the NK1 fragment of HGF/SF complexed with CHES
19. The structure of the NK1 fragment of HGF/SF complexed with MOPS
20. The structure of the NK1 fragment of HGF/SF
21. The structure of the NK1 fragment of HGF/SF complexed with 2FA
22. The structure of the NK1 fragment of HGF/SF complexed with PIPES
23. Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding
24. Effect of 2-benzo[d]thiazolyl-and 2-benzo[d]isothiazolyl-imino-5-benzydilene-4-thiazolidinone derivatives in human articular chondrocyte metabolism
25. G-triplex structure and formation propensity
26. Chondroprotective activity of 5-arylidene-4-thiazolidinone derivatives as new inhibitors of matrix metalloproteinase-13
27. Effect of 2-benzo[d]thiazolyl- and 2 benzo[d]isothiazolylimino-5-benzylidene-4-thiazolidone derivatives in human articular chondrocyte metabolism
28. Tuning sensitivity in paramagnetic NMR detection of ligand-DNA interaction
29. In situ AP/MALDI-MS characterization of anchored matrix metalloproteinases RID E-3893-2010
30. In Situ MALDI-MS characterization of MMPs anchored on gold surfaces
31. Preparation of arylsulfonamide-substituted hydroxamic acid derivatives as matrix metalloproteinases inhibitors
32. Activity of Anchored MMP1 On Au (111) Surfaces Monitored by ESI-MS
33. Coupling FT-SPR and ESI-MS techniques to monitor in a quantitative fashion the activity of two different MMPs anchored on a gold surface
34. X-ray structures of ternary enzyme-product-inhibitor complexes of MMP
35. Solvent 1H NMRD study of biotinylated paramagnetic liposomes containing Gd-bis-SDA-DTPA or Gd-DMPE-DTPA
36. Unraveling hidden allosteric regulatory sites in structurally homologues metalloproteases
37. Solution structure and dynamics of human S100A14
38. A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome.
39. Human MMP12 catalytic domain in complex with*N*-Hydroxy-2-(2-(4-methoxyphenyl)ethylsulfonamido)acetamide
40. Human MMP12 catalytic domain in complex with*N*-Hydroxy-2-(2-(4-methoxyphenyl)ethylsulfonamido)acetamide
41. Human MMP-12 catalytic domain in complex with*N*-Hydroxy-2-(2-phenylethylsulfonamido)acetamide
42. Human MMP-12 catalytic domain in complex with*(R)-N*-Hydroxy-1-(phenethylsulfonyl)pyrrolidine-2-carboxamide
43. Crystal structure of human MMP1 catalytic domain at 2.2 A resolution
44. Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-Hydroxy-2-(N-(2-hydroxyethyl)4-methoxyphenylsulfonamido)acetamide
45. Catalytic domain of human Serine/Threonine Phosphatase 5 (PP5c)with two Zn2+ atoms originally soaked with cantharidin (which is present in the structure in the hydrolyzed form)
46. Catalytic domain of human Serine/Threonine Phosphatase 5 (PP5c) with two Zn2+ atoms
47. Catalytic domain of human Serine/Threonine Phosphatase 5 (PP5c) with two Zn2+ atoms complexed with endothall
48. Catalytic domain of human Serine/Threonine Phosphatase 5 (PP5c) with two Mn2+ atoms originally soaked with norcantharidin (which is present in the structure in the hydrolyzed form)
49. Catalytic domain of human Serine/Threonine Phosphatase 5 (PP5c) with two Mn2+ atoms complexed with cantharidic acid
50. Catalytic domain of human Serine/Threonine Phosphatase 5 (PP5c) with two Mn2+ atoms complexed with endothall
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.